Genomics and epigenomics in rheumatic diseases: what do they provide in terms of diagnosis and disease management?

dc.creatorCastro-Santos P.
dc.creatorDíaz-Peña R.
dc.date.accessioned2020-09-02T22:14:21Z
dc.date.accessioned2022-11-08T20:19:48Z
dc.date.available2020-09-02T22:14:21Z
dc.date.available2022-11-08T20:19:48Z
dc.date.created2020-09-02T22:14:21Z
dc.date.issued2017
dc.identifier36, 9, 1935-1947
dc.identifier07703198
dc.identifierhttps://hdl.handle.net/20.500.12728/3963
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5143322
dc.languageen
dc.publisherSpringer London
dc.subjectBiomarker
dc.subjectDiagnosis
dc.subjectEpigenetics
dc.subjectEpigenomics
dc.subjectGenomics
dc.subjectRheumatic diseases
dc.subjectcytokine
dc.subjectankylosing spondylitis
dc.subjectArticle
dc.subjectclinical practice
dc.subjectdisease course
dc.subjectepigenetics
dc.subjectfollow up
dc.subjectgenetic association
dc.subjectgenetics
dc.subjectgenomics
dc.subjecthuman
dc.subjectmolecular biology
dc.subjectosteoarthritis
dc.subjectpathogenesis
dc.subjectpriority journal
dc.subjectrheumatic disease
dc.subjectrheumatoid arthritis
dc.subjectsystemic lupus erythematosus
dc.subjectdisease management
dc.subjectgenetic marker
dc.subjectgenetic predisposition
dc.subjectgenetics
dc.subjectphenotype
dc.subjectrheumatic disease
dc.subjectDisease Management
dc.subjectEpigenomics
dc.subjectGenetic Markers
dc.subjectGenetic Predisposition to Disease
dc.subjectGenomics
dc.subjectHumans
dc.subjectPhenotype
dc.subjectRheumatic Diseases
dc.titleGenomics and epigenomics in rheumatic diseases: what do they provide in terms of diagnosis and disease management?
dc.typeArticle


Este ítem pertenece a la siguiente institución